Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Sutro Biopharma (STRO) Non Operating Income (2017 - 2025)

Sutro Biopharma (STRO) has disclosed Non Operating Income for 4 consecutive years, with -$8.8 million as the latest value for Q4 2025.

  • Quarterly Non Operating Income fell 82.09% to -$8.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$32.8 million through Dec 2025, down 345.74% year-over-year, with the annual reading at -$32.8 million for FY2025, 345.69% down from the prior year.
  • Non Operating Income hit -$8.8 million in Q4 2025 for Sutro Biopharma, down from -$8.4 million in the prior quarter.
  • In the past five years, Non Operating Income ranged from a high of $19.1 million in Q3 2024 to a low of -$8.8 million in Q4 2025.